Select Language
Free Registration

Galectin-1

Galectin-1 Overview

English NameGalectin-1Approved Drugs1
Drugs in Clinical Trials1Target SynonymEpididymis Secretory Sperm Binding Protein，Lectin， Galactoside-Binding， Soluble， 1，Beta-Galactoside-Binding Lectin L-14-I，14 KDa Laminin-Binding Protein，S-Lac Lectin 1，14 KDa Lectin，Galaptin，HLBP14，Gal-1，HPL，Beta-Galactoside-Binding Protein 14kDa，Lectin Galactoside-Binding Soluble 1，GAL1，GBP，Galectin 1，Putative MAPK-activating protein PM12，Galectin-1，HBL，LGALS1，Lactose-binding lectin 1
Highest Development StageApproved
English NameGalectin-1
Target SynonymEpididymis Secretory Sperm Binding Protein，Lectin， Galactoside-Binding， Soluble， 1，Beta-Galactoside-Binding Lectin L-14-I，14 KDa Laminin-Binding Protein，S-Lac Lectin 1，14 KDa Lectin，Galaptin，HLBP14，Gal-1，HPL，Beta-Galactoside-Binding Protein 14kDa，Lectin Galactoside-Binding Soluble 1，GAL1，GBP，Galectin 1，Putative MAPK-activating protein PM12，Galectin-1，HBL，LGALS1，Lactose-binding lectin 1
Approved Drugs1
Drugs in Clinical Trials1
Highest Development StageApproved

Galectin-1 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Tag Free (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
GA1-H4113
Human
E. coli
Human Galectin-1 / LGALS1 Protein, Tag Free, low endotoxin (MALS verified)
Total: 1
  • 1

Galectin-1 Background

Galectin-1 (Gal-1), a member of the β-galactoside-binding animal lectin family, has a wide range of biological activities, which makes it an attractive target for medical applications. Gal-1 is ubiquitously but differentially expressed in normal and pathological animal tissues, and a variety of biological activities, including modulation of innate and adaptive immune responses, malignant progression of tumor cells, etc.

Galectin-1 Synonyms

LGALS1,GAL1,GBP,Galectin-1,DKFZp686E23103

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OlitigaltinGB-0139; TD-139Phase 2 ClinicalLund University Foundation, The University Of EdinburghCoronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17Arterial Occlusive Diseases; Diabetic macular oedema; Diabetic Retinopathy; Disease Progression; Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Vein Occlusion; Stroke; Uveitis; Venous Thrombosis; Vitreomacular Adhesion; Vitreous Detachment
Details

Product Reviews

  • L***h2021-12-13
    0People Like
    Human Galectin-1 / LGALS1 Protein, Tag Free, low endotoxin (MALS verified)
    Dear Sir or Madam, I had an overall good service from Acro Biosystems. Shipment was fast and product quality was good. Got the protocol for QC after asking the customer service. Protocol for QC was easy to understand and repeat. Easy way to download the Certificate of Analysis via the printed QR code on product vials. Customer service answered very fast and was very friendly. QC of Human Galectin-1 protein vs. biotinylated human CD45 protein (CD5-H82E7) was fine.
  • Overview
  • Product List
  • Marketed Drug Information
  • Product Reviews
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland